HIGHLIGHTS
- who: Guiming Niu and collaborators from the Shandong University, Jinan, China have published the research work: Bimetallic Nanomaterials: A Promising Nanoplatform for Multimodal Cancer Therapy, in the Journal: Molecules 2022, 27, x FOR PEER REVIEW of /2022/
- what: The aim of this review is to provide a comprehensive perspective on the recent progress of BNMs as therapeutic agents. The main motivation for the study comes from the remarkable properties, including com5. In the investigation, it is found that no matter which nanocarrier is used for tumor treatment, it only represents the volume and weight of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.